# SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis

> **NCT05041114** · NA · WITHDRAWN · sponsor: **Synchron Medical, Inc.**

## Conditions studied

- Neurologic Disorder
- Paralysis
- Paralysis; Stroke
- Amyotrophic Lateral Sclerosis
- Muscular Dystrophies
- Spinal Cord Injury
- Stroke, Lacunar
- Stroke, Brainstem
- Upper Limb Injury
- Spinal Muscular Atrophy

## Interventions

- **DEVICE:** Motor Neuroprosthesis

## Key facts

- **NCT ID:** NCT05041114
- **Lead sponsor:** Synchron Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-04-21
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study moved to U.S.
- **Last updated:** 2023-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05041114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05041114, "SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05041114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*